Effect of Echocardiography-Guided Left Ventricular Lead Placement for Cardiac Resynchronization Therapy on Mortality and Risk of Defibrillator Therapy for Ventricular Arrhythmias in Heart Failure Patients (from the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region [STARTER] Trial)

Echocardiography-guided left ventricular (LV) lead placement at the site of latest mechanical activation improves heart failure outcomes in patients receiving a cardiac resynchronization therapy defibrillator (CRT-D). In this study, we test the hypothesis that a strategy of echocardiography-guided L...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2014-05, Vol.113 (9), p.1518-1522
Main Authors: Adelstein, Evan, MD, Alam, Mian Bilal, MD, Schwartzman, David, MD, Jain, Sandeep, MD, Marek, Josef, MD, Gorcsan, John, MD, Saba, Samir, MD
Format: Article
Language:English
Subjects:
Aged
Arrhythmias, Cardiac - therapy
Cardiac Resynchronization Therapy - methods
Cardiac Resynchronization Therapy - mortality
Cardiology
Cardiovascular
Cardiovascular disease
Defibrillators - adverse effects
Double-Blind Method
Drug therapy
Echocardiography
Female
Follow-Up Studies
Heart attacks
Heart Failure - therapy
Heart Ventricles
Humans
Male
Prospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Echocardiography-guided left ventricular (LV) lead placement at the site of latest mechanical activation improves heart failure outcomes in patients receiving a cardiac resynchronization therapy defibrillator (CRT-D). In this study, we test the hypothesis that a strategy of echocardiography-guided LV lead placement improves patient survival rate free from appropriate CRT-D therapy for ventricular arrhythmias. Patients enrolled in the prospective, randomized Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial and treated with a CRT-D device (108 with the echo-guided strategy and 75 with the routine strategy) were followed to the end point of death or first appropriate CRT-D therapy. Over a follow-up period of 3.7 ± 2.1 years, 62 patients (33%) died and 40 (22%) received appropriate CRT-D therapy. Compared with the routine group, patients in the echo-guided group had improved CRT-D therapy-free survival rate (hazard ratio = 0.64, 95% confidence interval = 0.42 to 0.98, p = 0.038). Patients randomized to the echo-guided LV lead placement were more likely to resynchronize their LV compared with the routine group (72% vs 48%, respectively, p = 0.006). Patients whose LV did resynchronize after CRT-D had improved therapy-free survival rate compared with those whose LV did not resynchronize (hazard ratio = 0.49, 95% confidence interval = 0.28 to 0.86, p = 0.012). In conclusion, a strategy of echo-guided LV lead placement improved the patient survival rate free from defibrillator therapy in CRT-D recipients.
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2014.01.431